MondelezKimberly-Clark

Mondelez vs Kimberly-Clark

Global snacks and confectionery leader with strong brands vs Global maker of tissue and personal care products. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Mondelez International sells snacks, cookies, and chocolate under beloved brands like Oreo, Cadbury, and Toblerone to consumers in over 150 countries, using pricing power and emerging market growth to...

Why It’s Moving

Mondelez

MDLZ is holding near a steady analyst backdrop as recent target hikes signal confidence in brand strength and pricing power.

  • DA Davidson and Piper Sandler both raised their price targets to $64 while keeping Neutral ratings, signaling that recent results were solid enough to support modestly better expectations.
  • Broader Street sentiment remains constructive, with consensus ratings clustering around Buy or Moderate Buy, which shows analysts still see Mondelez as a defensive consumer name with earnings resilience.
  • The recent target revisions appear tied to brand investments and earnings outlooks, implying the market is weighing long-term pricing power against slower volume growth and cost pressure.
Sentiment:
⚖️Neutral
Kimberly-Clark

Kimberly-Clark is drawing cautious analyst optimism as the market weighs steady fundamentals against limited near-term catalysts.

  • Analyst sentiment is mostly neutral to mildly positive, which suggests investors see Kimberly-Clark as a steady defensive name rather than a fast-growth story.
  • The stock’s appeal is being tied to resilient household and personal-care demand, which can help support earnings even when broader consumer spending softens.
  • Recent forecast commentary points to valuation-supported upside, but the range of estimates remains wide, showing that the market is still debating how much growth the business can deliver.
Sentiment:
⚖️Neutral

Investment Analysis

Pros

  • Mondelez has a strong global brand portfolio including Oreo, Ritz, and CLIF Bar, supporting resilient top-line growth across diverse markets.
  • The company showed an adjusted EPS beat in Q3 2025 despite inflationary cost pressures, indicating operational profitability resilience.
  • Recent market valuation metrics suggest Mondelez is undervalued by about 64.6% based on discounted cash flow analysis, signaling potential long-term value.

Considerations

  • Mondelez's Q3 2025 revenue missed analyst expectations, leading to a negative investor reaction and stock price decline.
  • High cocoa costs have significantly impacted margins and represent a primary inflation-related challenge for the company’s snack segments.
  • The stock experienced a notable decline of approximately 14.6% over the past year, reflecting market concerns over growth prospects and margin sustainability.

Pros

  • Kimberly-Clark benefits from a strong and diversified portfolio in personal care products with significant market presence in North America and internationally.
  • The company maintains robust financial metrics including a net income of approximately $1.97 billion and a dividend yield near 5%, supporting income investors.
  • Kimberly-Clark's stock trades at a forward P/E of about 13.08, indicating relatively attractive valuation compared to industry peers.

Considerations

  • The stock has experienced a constrained 52-week trading range with limited upside momentum after peaks near $150, now trading closer to $100.
  • Kimberly-Clark faces competitive and cost pressures in personal care and tissue markets that may affect margin expansion.
  • Beta of 0.25 indicates low volatility, which may limit gains during strong market rallies for investors seeking growth.

Mondelez (MDLZ) Next Earnings Date

The next earnings date for MDLZ is typically expected around July 28, 2026, based on its recent reporting pattern, though the company has not formally confirmed it yet. This report would cover Q2 2026 results. If the schedule shifts, the announcement could fall within the last week of July.

Kimberly-Clark (KMB) Next Earnings Date

The next expected earnings date for KMB is August 7, 2026, based on current market estimates and its typical reporting pattern. The upcoming release should cover Q2 2026 results. This date is still an estimate, as Kimberly-Clark has not formally confirmed the announcement schedule.

Buy MDLZ or KMB in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

MDLZ
MDLZ$63.60
vs
KMB
KMB$102.05
Buy MDLZ